Finally, we note that in setting up the vaccine programme the Department provided indemnities to vaccine manufacturers, which gave cover for future claims against producers for any adverse effects of their vaccines. These indemnities may add to the costs of the programme in the long term.80 We heard from one individual whose relative had suffered side-effects as a result of vaccination. Their evidence underlined the importance of having clear, prompt and adequate compensation. arrangements fo...

Finally, we note that in setting up the vaccine programme the Department provided indemnities to vaccine manufacturers, which gave cover for future claims against producers for any adverse effects of their vaccines. These indemnities may add to the costs of the programme in the long term.80 We heard from one individual whose relative had suffered side-effects as a result of vaccination. Their evidence underlined the importance of having clear, prompt and adequate compensation. arrangements for people in need. The Department told us it had a substantial number of contingent liabilities related to 73 Q66; C&AG’s Report, paras 15 and 2.19 74 C&A Type: conclusion | Number: 32 | Response status: not_addressed